HOME >> MEDICINE >> NEWS
Controlling neglected tropical diseases could help make poverty history

"The big three" infections AIDS, TB and malaria have caught the world's attention but other disabling and fatal infectious diseases in Africa are being ignored, say three eminent tropical disease researchers in the international health journal PLoS Medicine.

The neglected tropical diseases, which include sleeping sickness, schistosomiasis, river blindness, hookworm, elephantiasis, and blinding trachoma, affect several hundred million people, and kill at least half a million annually, and yet they garner little attention from donors, policymakers, and public health officials.

The researchers, led by Professor David Molyneux, Director of the Lymphatic Filariasis Support Centre at the Liverpool School of Tropical Medicine, argue that a "rapid impact package""Xdistribution of four anti-parasitic drugs across Africa to treat seven neglected diseases"Xwould bring tangible benefits to the world"'s poorest communities.

The cost of the package, they say, would be negligible"Xa mere 40 cents per person per year, compared with a minimum of $200 per person per year to treat HIV/AIDS, $200 to treat a single episode of TB, and $7-10 to treat a single episode of malaria.

Three of the drugs in the package (ivermectin, azithromycin, and albendazole) are being donated by their manufacturers, and the fourth (praziquantel) now costs only 7 cents per tablet.

Professor Molyneux and his colleagues, Professor Peter Hotez of the Human Hookworm Initiative and Professor Alan Fenwick of the Schistosomiasis Control Initiative, argue that a rapid impact package against some of the neglected tropical diseases could permanently reduce their incidence.

For costs that are relatively modest compared to controlling "the big three,"an integrated control package for neglected tropical diseases could have a proportionately greater impact on more poor people's health as well as being more equitable for the majority of Africa's poorest and margi
'"/>

Contact: Paul Ocampo
press@plos.org
415-624-1224
Public Library of Science
10-Oct-2005


Page: 1 2

Related medicine news :

1. Controlling prescription drug expenditures: a case report of success
2. Controlling antibiotics and antibiotic resistance in hospitals
3. Controlling behavior of children with tourette and tic disorders
4. Controlling blood sugar in hospitalized patients saves lives
5. Controlling your (nerve) impulses
6. Controlling neglected tropical diseases will boost fight against HIV, TB, and malaria
7. Public Library of Science to launch new, open access journal on neglected tropical diseases
8. The Lancet calls on research community to address neglected disease that causes heart failure
9. Health-care needs of trafficked women are being neglected
10. Research to improve trauma patient care neglected
11. Innovate or perish? Helping developing countries fight neglected diseases

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/17/2017)... ... January 17, 2017 , ... Mirror Mirror Beauty Boutique, ... highest honor of Diamond Level in Zeltiq’s Crystal Rewards Program. Practice founder, Paul Vitenas, ... this elite group of providers. , Produced by Zeltiq, CoolSculpting is approved by ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... will lecture to primary eye care practitioners on the latest breakthroughs in the ... 13th Semi-Annual Continuing Education Symposium, according to eye surgeon, Jeffrey Martin, MD, FACS, ...
(Date:1/17/2017)... ... January 17, 2017 , ... Neil H. Greco Insurance Agency, a northern New ... the region, is launching a charity drive to raise awareness of heart disease and ... killer in America, and is responsible for 1 in every 4 deaths at the ...
(Date:1/17/2017)... ... January 17, 2017 , ... Livionex, Inc., a Silicon Valley ... double blind clinical study for its dental gel that shows significant reduction in plaque ... toothpaste containing triclosan. The study was conducted at the Beckman Laser Institute at UC ...
(Date:1/17/2017)... Tyler, TX (PRWEB) , ... January 17, 2017 ... ... serving Texas families from two offices in Tyler, has announced the latest beneficiary ... Red Ribbon Wish Network, a nonprofit organization dedicated to fulfilling the dreams of ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... Inc ., a clinical-stage, cancer-selective gene therapy company, today announced ... development at Tocagen, will present at Phacilitate Cell & Gene ... Miami . Details of the podium ... ... what to do when and why Date and Time: Wednesday, Jan. ...
(Date:1/17/2017)... Research and Markets has announced the addition ... Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biotech), Product (mAb, Hormone) Drug (OTC, ... report to their offering. ... The global active pharmaceutical ingredients market is expected ... in 2016, growing at a CAGR of 6.3% from 2016 to ...
(Date:1/17/2017)... -- Immune Pharmaceuticals (NASDAQ: IMNP ) ("Immune"), ... will hold a Satellite Symposium on February 20th, 2017 at ... Munich, Germany . The ... for the maintenance of remission in AML with Ceplene" ... 2017 from 12:45 – 13:45 CET in Lecture Hall ...
Breaking Medicine Technology:
Cached News: